You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动 | 李氏大药厂(0950.HK)高开10.14% 拟分拆兆科眼科于联交所主板上市
格隆汇 12-21 09:24
格隆汇12月21日丨李氏大药厂(0950.HK)高开10.14%,报4.78港元,最新总市值28亿港元。李氏大药厂上周五(18日)晚间发布公告,就有关可能将兆科眼科分拆及独立上市。董事会欣然宣布于12月18日向联交所呈交上市申请表格(A1表格),以申请批准兆科普通股以全球发售方式于联交所主板上市及买卖。建议分拆涉及将兆科集团分拆及以兆科普通股独立上市。于本公布日期,公司间接拥有兆科眼科约34.107%权益,为公司的联营公司。于建议分拆完成时,预计本公司将不再为兆科眼科的控股股东,惟仍将为兆科眼科的单一最大股东。兆科眼科的经营业绩并无亦不会于本公司的综合财务报表中综合入账。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account